Specific Diagnostics has developed a new technology that determines the effective antibiotic for bloodstream infections leading to sepsis in less than 1 day, reducing mortality rates and hospital costs. Their Reveal instrument and assay are cost-effective and labor-saving, streamlining lab workflow and speeding up time-to-answer. The company's patented technology leverages a low-cost small molecule sensor (SMS) array, enabling diagnostic products that simplify workflow and speed time-to-answer at low cost. Specific is located in Mountain View, California.